At Sass & Sass, Inc., we are committed to research and development of immunomodulatory therapeutics based on lower-molecular weight substances which can be better characterized. Use of lower-molecular weight substances allows for a rigorous, structure-based quality control which is essential to provide guarantees to our customers that our products are "safe, potent and efficacious"*.

* Virus, Serum and Toxin Act, 1931

Sass & Sass, Inc. has been awarded US patent 6,525,035 "Therapeutic composition and methods", and has another patent application pending.